Bryn Mawr Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.08M | Buy |
5,233
+52
| +1% | +$40.5K | 0.22% | 96 |
|
|
2025
Q1 | $4.28M | Sell |
5,181
-448
| -8% | -$370K | 0.26% | 93 |
|
|
2024
Q4 | $4.35M | Buy |
5,629
+761
| +16% | +$588K | 0.23% | 94 |
|
|
2024
Q3 | $4.31M | Sell |
4,868
-19
| -0.4% | -$16.8K | 0.23% | 93 |
|
|
2024
Q2 | $4.38M | Sell |
4,887
-1,652
| -25% | -$1.48M | 0.24% | 94 |
|
|
2024
Q1 | $3.98M | Buy |
6,539
+1,481
| +29% | +$902K | 0.23% | 101 |
|
|
2023
Q4 | $2.95M | Buy |
5,058
+1,732
| +52% | +$1.01M | 0.18% | 116 |
|
|
2023
Q3 | $1.79M | Buy |
3,326
+1,981
| +147% | +$1.06M | 0.12% | 152 |
|
|
2023
Q2 | $631K | Buy |
1,345
+235
| +21% | +$110K | 0.06% | 196 |
|
|
2023
Q1 | $381K | Sell |
1,110
-52
| -4% | -$17.9K | 0.04% | 215 |
|
|
2022
Q4 | $425K | Buy |
+1,162
| New | +$425K | 0.05% | 201 |
|